Des-acyl ghrelin fragments evoke endothelium-dependent vasodilatation of rat mesenteric vascular bed via activation of potassium channels

European Journal of Pharmacology

Volumn 604, Issue 1-3, 2009, Pages 79-86

  Moazed, Banafsheh ^a   Quest, Dale ^a   Gopalakrishnan, Venkat ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Acetylcholine; Calcium activated potassium channel; Des acyl ghrelin; Endothelium; Ghrelin; l serine; Mesenteric vascular bed; Phenylephrine; Vasodilatation

Indexed keywords

1,2 CHLOROPHENYLDIPHENYL 1H PYRAZOLE; ACETYLCHOLINE; APAMIN; BARIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; DESACYLGHRELIN; GHRELIN; GLYCINE; GROWTH HORMONE RELEASING FACTOR; NITRIC OXIDE SYNTHASE; OUABAIN; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE; PYRAZOLE DERIVATIVE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; ENZYME INHIBITION; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; BIOLOGICAL FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GHRELIN; MALE; MESENTERIC ARTERIES; MESENTERIC VEINS; PEPTIDE FRAGMENTS; PERFUSION; PHENYLEPHRINE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 58949092112     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.032     Document Type: Article

References (40)

1. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolimo F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., and Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI3-kinase/AKT. J. Cell. Biol. 159 (2002) 1029-1037
2. Bedendi I., Alloatti G., Marcantoni A., Malan D., Catapano F., Ghe C., Deghenghi R., Ghigo E., and Muccioli G. Cardiac effects of ghrelin and its endogenous derivatives desoctanoyl ghrelin and des-Gln14-ghrelin. Eur. J. Pharmacol. 476 (2003) 87-95
3. Bedendi I., Gallo M.P., Malan D., Levi R.C., and Alloatti G.L.S. Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle. Life Sci. 69 (2001) 2189-2201
4. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., and Weston A.H. EDHF: bringing the concepts together. Trends. Pharmacol. Sci. 23 (2002) 374-380
5. Busse R., Fichtner H., Luckhoff A., and Kohlhardt M. Hyperpolarization and increased free calcium in acetylcholine-stimulated endothelial cells. Am. J. Physiol. Heart. Circ. Physiol. 255 (1988) H965-H969
6. Chilian W.M., and Koshida R. EDHF and NO: different pathways for production-similar actions. Circ. Res. 89 (2001) 648-649
7. Christensen K.L., and Mulvany M.J. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J. Vasc. Res. 30 (1993) 73-79
8. Davenport A.P., Bonner T.I., Foord S.M., Harmar A.J., Neubig R.R., Pin J.P., Spedding M., Kojima M., and Kangawa K. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol. Rev. 57 (2005) 541-546
9. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396 (1998) 269-272
10. Félétou M., and Vanhoutte P.M. Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann. Med. 39 (2007) 495-516
11. Herrington J., and Hille B. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 135 (1994) 1100-1108
12. Henriques-Coelho T., Correia-Pinto J., Roncon-Albuquerque Jr. R., Baptista M.J., Lourenco A.P., Oliveira S.M., Brandao-Nogueira A., Teles A., Fortunato J.M., and Leite-Moreira A.F. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) H2885-H2890
13. Katugampola S.D., Maguire J.J., Kuc R.E., Wiley K.E., and Davenport A.P. Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can. J. Physiol. Pharmacol. 80 (2002) 369-374
14. Kleinz M.J., Maguire J.J., Skepper J.N., and Davenport A.P. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc. Res. 69 (2006) 227-235
15. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
16. Kojima M., Hosoda H., Matsuo H., and Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends. Endocrinol. Metab. 12 (2001) 118-122
17. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., McCormick M.L., Sigmund C.D., Tang C., and Weintraub N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-kB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
18. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kangawa K., and Kawarabayashi T. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 39 (2002) 781-784
19. Mather S., Dora K.A., Sandow S.L., Winter P., and Garland C.J. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries. Circ. Res. 97 (2005) 399-407
20. Matsumoto M., Hosoda H., Kitajima Y., Morozumi N., Minamitake Y., Tanaka S., Matsuo H., Kojima H., Hayashi Y., and Kangawa K. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem. Biophys. Res. Commun. 287 (2001) 142-146
21. Mishra R.C., Tripathy S., Desai K.M., Quest D., Lu Y., Akhtar J., and Gopalakrishnan V. Nitric oxide synthase inhibition promotes endothelium-dependent vasodilatation and the antihypertensive effect of l-serine. Hypertension 51 (2008) 791-796
22. Misurski D., Tatchum-Talom R., McNeill J.R., and Gopalakrishnan V. Vanadate-evoked relaxation of the perfused rat mesenteric vascular bed. Life Sci. 67 (2000) 1369-1379
23. Misurski D.A., Wu S.Q., McNeill J.R., Wilson T.W., and Gopalakrishnan V. Insulin-induced biphasic responses in rat mesenteric vascular bed: role of endothelin. Hypertension 37 (2001) 1298-1302
24. Muccioli G., Pons N., Ghe C., Catapano F., Granata R., and Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur. J. Pharmacol. 498 (2004) 27-35
25. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Shimizu W., Hosoda H., and Kojima M. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1483-R1487
26. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., Kojima M., Nakanishi N., Mori H., and Kangawa K. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J. Clin. Endocrinol. Metab. 86 (2001) 5854-5859
27. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., and Matsukura S. Role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
28. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., and Kangawa K. Vasodilator effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol. 39 (2002) 779-783
29. Pemberton C.J., Tokola H., Bagi Z., Koller A., Pontinen J., Ola A., Vuolteenaho O., Szokodi I., and Ruskoaho H. Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) H1522-H1529
30. Poykko S.M., Kellokoski E., Horkko S., Kauma H., Kesaniemi A., and Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
31. Rossi F., Bertone C., Petricca S., and Santiemma V. Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells. Atherosclerosis 192 (2007) 291-297
32. Shinde U., Desai K.M., Yu C., and Gopalakrishnan V. Nitric oxide synthase inhibition exaggerates the hypotensive response to ghrelin: role of calcium-activated potassium channels. J. Hypertens. 23 (2005) 779-784
33. Ca channels. Peptides 27 (2006) 1616-1623
34. Tesauro M., Schinzari F., Iantorno M., Rizza S., Melina D., Lauro D., and Cardillo C. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112 (2005) 2986-2992
35. Thompson N.M., Gill D.A.S., Davies R., Loveridge N., Houston P.A., Robinson I.C.A.F., and Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 (2004) 234-242
36. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
37. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
38. Vequaud P., and Thorin E. Endothelial G protein beta-subunits trigger nitric oxide-but not endothelium-derived hyperpolarizing factor-dependent dilatation in rabbit resistance arteries. Circ. Res. 89 (2001) 716-722
39. Wiley K.E., and Davenport A.P. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J. Pharmacol. 136 (2002) 1146-1152
40. Wu R., Zhou M., Cui X., Simms H.H., and Wang P. Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) H1296-H1302